Dexcom Inc (NASDAQ: DXCM) is -41.29% lower on its value in year-to-date trading and has touched a low of $62.34 and a high of $142.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DXCM stock was last observed hovering at around $77.69 in the last trading session, with the day’s loss setting it -4.84%.
Currently trading at $72.85, the stock is -5.32% and -26.41% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.58 million and changing -6.23% at the moment leaves the stock -37.84% off its SMA200. DXCM registered -31.31% loss for a year compared to 6-month loss of -38.19%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -34.75% gain in the last 1 month and extending the period to 3 months gives it a -44.26%, and is 2.58% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.05% over the week and 4.83% over the month.
Dexcom Inc (DXCM) has around 9600 employees, a market worth around $29.19B and $3.93B in sales. Current P/E ratio is 44.89 and Fwd P/E is 36.19. Profit margin for the company is 16.95%. Distance from 52-week low is 16.86% and -48.70% from its 52-week high. The company has generated returns on investments over the last 12 months (13.32%).
The EPS is expected to grow by 11.66% this year.
Dexcom Inc (DXCM) Top Institutional Holders
1487.0 institutions hold shares in Dexcom Inc (DXCM), with institutional investors hold 98.75% of the company’s shares. The shares outstanding are 400.73M, and float is at 394.61M with Short Float at 1.79%. Institutions hold 98.45% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 44.6 million shares valued at $6.19 billion. The investor’s holdings represent 11.431 of the DXCM Shares outstanding. As of 2024-03-31, the second largest holder is BLACKROCK INC. with 33.92 million shares valued at $4.71 billion to account for 8.6937 of the shares outstanding. The other top investors are STATE STREET CORP which holds 16.21 million shares representing 4.1555 and valued at over $2.25 billion, while BAILLIE GIFFORD & CO holds 4.0206 of the shares totaling 15.69 million with a market value of $2.18 billion.
Dexcom Inc (DXCM) Insider Activity
The most recent transaction is an insider sale by Brown Michael Jon, the company’s EVP, Chief Legal Officer. SEC filings show that Brown Michael Jon sold 652 shares of the company’s common stock on Jul 31 ’24 at a price of $69.55 per share for a total of $45347.0. Following the sale, the insider now owns 66249.0 shares.
Still, SEC filings show that on Jun 28 ’24, Brown Michael Jon (EVP Chief Legal Officer) disposed off 659 shares at an average price of $114.29 for $75317.0. The insider now directly holds 66,901 shares of Dexcom Inc (DXCM).
